Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement.  Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.

MORE NEWS
  • 11Jul

    Winner A3P Conference

    Read More →
  • 17Jun

    Microcoat announces the 10th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 02Mai

    Ausbildung

    Read More →
  • 20Mrz

    Meet us at Analytica 2024

    Read More →
  • 08Jan

    Low Endotoxin Recovery/Masking Training Course Munich/Bernried, GERMANY

    Read More →
  • 25Sep

    Meet us at PDA 2023

    Read More →
  • 28Aug

    Microcoat announces the 9th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 05Jun

    Tag der Ausbildung bei Microcoat. Sei dabei!

    Read More →
  • 31Mrz

    Mach, was dir gefällt! Microcoat ist Teil des Boys Day

    Read More →
  • 23Mrz

    Microcoat ist dabei! Ausbildungskampagne #Könnenlernen

    Read More →